We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 875

CMS finalizes rules for end-stage renal disease dialysis payment system, incentive program
  • McGuireWoods LLP
  • USA
  • November 4 2014

On Friday, Oct. 31, 2014, the Centers for Medicare and Medicaid Services (CMS) published a final rule regarding the end-stage renal disease (ESRD


FDA’s recent two-pronged attack on drug shortages
  • McGuireWoods LLP
  • USA
  • December 11 2013

On November 4, 2013, FDA issued a proposed rule regarding manufacturer notification to FDA of drug shortages due to a permanent discontinuance or


Weekly Washington healthcare update - May 11, 2015
  • McGuireWoods LLP
  • USA
  • May 11 2015

On May 5, Reps. Phil Roe, M.D. (R-TN), and Linda Sánchez (D-CA) announced that their legislation to repeal the Independent Payment Advisory Board


Avelox approved for plague under animal efficacy rule
  • McGuireWoods LLP
  • USA
  • May 11 2015

On May 8, 2015, FDA approved a new antibacterial treatment for plague, Avelox (moxifloxacin). Plague is a deadly infectious disease caused by the


NaviMed Capital closes new $110 million healthcare PE fund
  • McGuireWoods LLP
  • USA
  • July 20 2015

NaviMed Capital has announced the closing of its inaugural healthcare private equity fund, NaviMed Partners, LP. The fund has more than $110 million


Hospital’s cloud-based document-sharing practices lead to $218,400 HIPAA settlement
  • McGuireWoods LLP
  • USA
  • July 21 2015

On July 10, 2015, the U.S. Department of Health and Human Services Office for Civil Rights (OCR) announced a substantial settlement with St


Weekly Washington healthcare update - March 2, 2015
  • McGuireWoods LLP
  • USA
  • March 2 2015

Ways and Means Advances Four Health-Related Measures... Senate Commerce Committee Clears Legislation on E-Cigarette Packaging... CMS Pushes Back


Amarin wins truthful off-label speech challenge
  • McGuireWoods LLP
  • USA
  • August 10 2015

On August 7, Citing the First Amendment, a Southern District of New York court ruled that FDA cannot limit a manufacturer's "truthful and


Weekly Washington healthcare update - December 15, 2014
  • McGuireWoods LLP
  • USA
  • December 15 2014

Congress Averts Government Shutdown By Passing Long-Term Funding Measure... Office of the National Coordinator for Health Information Technology


Weekly Washington healthcare update - August 11, 2015
  • McGuireWoods LLP
  • USA
  • August 10 2015

Bipartisan Senate Letter Questions HHS and CMS on Details of State ACA Waivers...OMB Is Reviewing Final Medicaid-Covered Outpatient Drug Rule